BofA Securities analyst Craig Bijou lowered the price target on RxSight Inc. (NASDAQ: RXST) to $6.50 (from $8.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

RxSight (RXST) Reiterated at Hold by Stifel as ALC Collaboration AnnouncedJuly 7, 2026 6:56 AM Alcon and RxSight team up to develop light-adjustable cataract lensesJuly 6, 2026 4:16 PM Form 8-K RxSight, Inc. For: Jul 06July 6, 2026 4:15 PM RxSight cuts 2026 sales outlook, citing competitive headwindsJuly 6, 2026 4:15 PM Form 8-K RxSight, Inc. For: Jun 30July 6, 2026 4:15 PM RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration AgreementJuly 6, 2026 4:15 PM RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement July 6, 2026 4:15 PM